Form 4 Filing for Anixa Biosciences Inc.

This filing details a transaction by Lewis H. Titterton Jr., a director at Anixa Biosciences Inc. (ANIX). On July 20, 2026, Mr. Titterton acquired 12,000 shares of Common Stock at a price of $3.47 per share. Following this transaction, his total ownership of Anixa Biosciences Inc. common stock increased to 986,967 shares. The transaction was directly owned.